Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 74Other solid neoplasm 8Gastrointestinal 5Head & Neck 3CNS 3Tumor-Agnostic 2Gynecologic 2Dermatologic 2Sarcoma 1

Conditions

Sarcoma, Ewing 1Sarcoma 1

Interventions

Specimen Handling 27Magnetic Resonance Spectroscopy 23Cyclophosphamide 16Biopsy 15Doxorubicin 14pembrolizumab 12X-Rays 12Radiation 12Radiotherapy 10Temozolomide 9Phantoms, Imaging 9Vincristine 7Irinotecan 7Nivolumab 6Ifosfamide 6atezolizumab 5Gemcitabine 5palbociclib 4liposomal doxorubicin 4fludarabine 4cemiplimab 4cabozantinib 4Immunoglobulin G 4Imatinib Mesylate 4Etoposide 4Dactinomycin 4Carboplatin 4Bevacizumab 4selinexor 3olaparib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pemetrexed × Sarcoma × 30 days × Clear all
NCT03715933 2026-05-22

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Inhibrx Biosciences, Inc

Phase 1 Recruiting
411 enrolled
Sarcoma

Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡